Chemical Structure (Emtriva 01)
Emtriva Capsule
Product Images NDC 61958-0601
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtriva (NDC 61958-0601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Emtriva 02)
Principal Display Panel (Representative Bottle Label)
Emtriva® Capsule contains 200mg of Emtricitabine. It is a prescription medicine used for HIV-1 infection treatment. The medicine is provided in capsules, and each bottle contains 30 capsules. It should be stored at 25°C and kept tightly closed. The package insert should be consulted for dosage and administration instructions. The medicine is manufactured in Germany by Gilead Sciences, Inc.*
Principal Display Panel
This is a medication package for Emtriva (emtricitabine) Oral Solution with a concentration of 10mg/mL. The package contains 170mL of solution with instructions of use and dosage given in the package insert. The solution should be stored refrigerated between 2-8°C (36-46°F) and should be used within three months if stored by the patient at 25°C (77°F), with excursions permitted to 15-30°C (59-86°F). The container should be kept tightly closed. The medication is manufactured for Gilead Sciences, Inc. in Foster City, CA, USA, and made in Canada. The package has an NDC code of 61958-0602-1 and an expiration date that is not provided in the text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
